Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-25T00:22:39.710Z Has data issue: false hasContentIssue false

A Pilot Study on the Use of Botulinum Toxin in Spasmodic Torticollis

Published online by Cambridge University Press:  18 September 2015

J.K. Tsui*
Affiliation:
Division of Neurology, University of British Columbia, Health Science Centre Hospital, Vancouver
A. Eisen
Affiliation:
Department of Ophthalmology, University of British Columbia
E. Mak
Affiliation:
Department of Ophthalmology, University of British Columbia
J. Carruthers
Affiliation:
Department of Ophthalmology, University of British Columbia
A. Scott
Affiliation:
Department of Ophthalmology, University of British Columbia
D.B. Calne
Affiliation:
Department of Ophthalmology, University of British Columbia
*
Division of Neurology, Health Sciences Centre Hospital, 2211 Westbrook Mall, University of British Columbia, Vancouver, British Columbia, Canada V6T 1W5
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Dystonic torticollis has been treated with local injections of botulinum toxin in a single blind study of 12 patients. A significant decrease of abnormal movements was recorded, and pain improved. Further studies are desirable to define the optimum dosage and site for injections, and the long term effects of repeated injections.

Type
Original Articles
Copyright
Copyright © Canadian Neurological Sciences Federation 1985

References

REFERENCES

Alpers, BJ, Drayer, CS (1937) The organic background of some cases of spasmodic torticollis. Am J Med Sci 193: 378384.CrossRefGoogle Scholar
Couch, JR (1976) Dystonia and tremor in spasmodic torticollis. Advances in Neurology Vol 14 edited by Eldridge, and Fahn, , Raven Press, N.Y.Google Scholar
Foerster, O (1933) Mobile spasm of the neck muscles and its pathological basis. J Comp Neurol 58: 725735.CrossRefGoogle Scholar
Frueh, BR, Felt, DP, Wojno, TH, Musch, DC (1984) Treatment of blepharospasm with botulinum toxin. Arch Ophthalmol 102: 14641468.CrossRefGoogle ScholarPubMed
Grinker, RR, Walker, AC (1933) The pathology of spasmodic torticollis with a note on respiratory failure from anaesthesia in chronic encephalitis. J Nerv Ment Dis 78: 430437.CrossRefGoogle Scholar
Hassler, R, Dieckmann, G (1970) Stereotactic treatment of different kinds of spasmodic torticollis. Confín Neurol 32: 135143.CrossRefGoogle ScholarPubMed
Lai, S. (1979) Pathophysiology and pharmacotherapy of spasmodic torticollis: a review. Can J Sci Neurol 6: 427435.Google Scholar
Marsden, CD, Harrison, MJG (1974) Idiopathic torsion dystonia (Dystonia musculorum deformans), a review of forty-two patients. Brain 97: 793810.CrossRefGoogle ScholarPubMed
Matthews, WB, Beasley, P, Parry-Jones, W, Garland, G (1978) Spasmodic torticollis: a combined clinical study. J Neurol Neurosurg Psychiat 41: 485492.CrossRefGoogle ScholarPubMed
Meares, R (1971) Natural history of spasmodic torticollis, and effect of surgery. Lancet 2: 149151.CrossRefGoogle ScholarPubMed
Podivinsky, F (1968) Torticollis. In: Handbook of Clinical Neurology, Vol 6, edited by Vinken and Bruyn, North-Holland, Amsterdam. 567603.Google Scholar
Sanders, DB, Massey, EW, Buckley, EC (1985) EMG monitoring of botulinum toxin in blepharospasm. Neurology 35 (Supp 1): 272.Google Scholar
Schaltenbrand, G (1938) Klinik und behandlung des Torticollis spasticus. Dtsch? Nervenheilk 145: 3653.CrossRefGoogle Scholar
Schwind, VF, Schutz, E (1960) Beitrag zur konservativen Behandlung des Torticollis spasticus. Der Nervenartz 31: 318319.Google Scholar
Scott, AB, Rosenbaum, AL, Collins, CC (1973) Pharmacologic weakening of extraocular muscles. Invest Ophthalmol 12: 924927.Google ScholarPubMed
Scott, AB (1980) Botulinum toxin injection into extraocular muscles as an alternative to stabismus surgery. Ophthalmology 87: 10441047.CrossRefGoogle Scholar